Gufic Biosciences Share PriceGufic BioSciences

₹286.9
0.15 (0.05%)
As on 01 October, 2023 | 10:09 BSE: 509079 NSE: GUFICBIOISIN: INE742B01025

Gufic Biosciences Performance

Day Range

  • Low 285.6
  • High 295.9
286.9

52 Week Range

  • Low 177.65
  • High 333
286.9
  • Open Price287.6
  • Previous Close286.75
  • Volume105354

Start SIP in Gufic BioSciences

Start SIP

Gufic Biosciences Share Price

  • Over 1 Month -5.8%
  • Over 3 Month 22.14%
  • Over 6 Month 52.57%
  • Over 1 Year 32.67%

Gufic Biosciences Key Statistics

P/E Ratio 35.1
PEG Ratio -4.7
Market Cap Cr 2,781
Price to Book Ratio 8
EPS 8.2
Dividend 0
Relative Strength Index 49.01
Money Flow Index 65.8
MACD Signal 3.16
Average True Range 12.11

Gufic Biosciences Investment Rating

  • Master Rating:
  • Gufic Biosciences has an operating revenue of Rs. 720.36 Cr. on a trailing 12-month basis. An annual revenue de-growth of -11% needs improvement, Pre-tax margin of 15% is great, ROE of 22% is exceptional. The company has a debt to equity of 55%, which is bit higher. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 25% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 81 which is a GOOD score indicating consistency in earnings, a RS Rating of 68 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 87 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Gufic BioSciences Financials
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 195173177175165162
Operating Expenses Qtr Cr 160141144142132131
Operating Profit Qtr Cr 353233333332
Depreciation Qtr Cr 465544
Interest Qtr Cr 432211
Tax Qtr Cr 767776
Net Profit Qtr Cr 211820202120
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 693782
Operating Expenses Annual Cr 556633
Operating Profit Annual in Cr 135146
Depreciation Cr 2217
Interest Annual Cr 85
Tax Annual Cr 2731
Net Profit Annual Cr 8096
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 104
Cash from Investing Activity Annual Cr -96
Cash from Financing Annual Activity Cr -3
Net Cash Flow Annual Cr 5
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 348269
Fixed Assets Annual Cr 329156
Total Non Current Assets Annual Cr 397201
Total Current Assets Annual Cr 464321
Total Assets Annual Cr 861521
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 3628
ROE Annual % 2336
ROCE Annual % 2039
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2019
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Gufic Biosciences Technicals

EMA & SMA

Current Price
₹286.9
0.15 (0.05%)
  • Bullish Moving Average
  • ___
  • 9
  • Bearish Moving Average
  • ___
  • 7
  • 20 Day
  • ₹289.66
  • 50 Day
  • ₹278
  • 100 Day
  • ₹258.68
  • 200 Day
  • ₹240.59
  • 20 Day
  • ₹296.36
  • 50 Day
  • ₹279.94
  • 100 Day
  • ₹248.3
  • 200 Day
  • ₹229.19

Gufic Biosciences Resistance and Support

PIVOT
₹289.47
Resistance
First Resistance ₹293.34
Second Resistance ₹299.77
Third Resistance ₹303.64
RSI 49.01
MFI 65.8
MACD Single Line 3.16
MACD 0.64
Support
First Resistance ₹283.04
Second Resistance ₹279.17
Third Resistance ₹272.74

Gufic Biosciences Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 114,832 3,119,985 27.17
Week 111,783 4,394,198 39.31
1 Month 300,449 10,873,254 36.19
6 Month 270,523 11,616,252 42.94

Gufic Biosciences Result Highlights

Gufic BioSciences Synopsis

NSE-Medical-Generic Drugs

Gufic Biosciences Lt is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 690.62 Cr. and Equity Capital is Rs. 9.69 Cr. for the Year ended 31/03/2023. Gufic BioSciences Ltd. is a Public Limited Listed company incorporated on 23/07/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24100MH1984PLC033519 and registration number is 033519.
Market Cap 2,781
Sales 720
Shares in Float 2.42
No of funds 11
Yield 0.03
Book Value 8
U/D Vol ratio 1.6
LTDebt / Equity 55
Alpha 0.1
Beta 0.73

Gufic BioSciences

Owner NameJun-23Mar-23Dec-22Sep-22
Promoters 75%75%75%75%
Mutual Funds 1.03%1.03%1.03%1.03%
Foreign Portfolio Investors 0.7%0.72%0.16%0.06%
Individual Investors 17.83%17.83%18.24%18.28%
Others 5.44%5.42%5.57%5.63%

Gufic BioSciences Management

Name Designation
Mr. Jayesh P Choksi Chairman & Managing Director
Mr. Pranav J Choksi WholeTime Director & CEO
Mr. Pankaj J Gandhi Whole Time Director
Mr. Dilip B Ghosh Whole Time Director
Dr. Balram H Singh Non Exe.Non Ind.Director
Mr. Rabi N Sahoo Independent Director
Mr. Gopal M Daptari Independent Director
Mr. Shreyas K Patel Independent Director
Mr. Shrirang V Vaidya Independent Director
Dr. Anu S Auora Independent Director

Gufic Biosciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Gufic Biosciences Corporate Action

Date Purpose Remarks
2023-08-11 Quarterly Results & ESOP
2023-05-29 Audited Results & Final Dividend
2023-02-10 Quarterly Results
2022-11-11 Quarterly Results
2022-08-11 Quarterly Results

Gufic BioSciences MF Shareholding

Name Amount(cr)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth 3174
SBI Healthcare Opportunities Fund Regular Payout Inc Dist cum Cap Wdrl 2033
Quant Business Cycle Fund Regular Growth 426
Motilal Oswal Nifty Microcap 250 Index Fund Regular Growth 324
Quant Healthcare Fund Regular Growth 137
  • Company Name
  • CMP
  • Chg(%)
  • Company Name
  • CMP
  • Chg(%)

Gufic BioSciences FAQs

What is Share Price of Gufic BioSciences ?

Gufic BioSciences share price is ₹286 As on 01 October, 2023 | 09:55

What is the Market Cap of Gufic BioSciences ?

The Market Cap of Gufic BioSciences is ₹2781.3 Cr As on 01 October, 2023 | 09:55

What is the P/E ratio of Gufic BioSciences ?

The P/E ratio of Gufic BioSciences is 35.1 As on 01 October, 2023 | 09:55

What is the PB ratio of Gufic BioSciences ?

The PB ratio of Gufic BioSciences is 8 As on 01 October, 2023 | 09:55

Q2FY23